Efficacy of sinecatechins 10% as proactive sequential therapy of external and perianal genital warts after laser therapy: An exploratory trial

Background: External genital warts (EGW) are the most common viral sexually transmitted infection. Ablative treatments like cryotherapy, curettage and CO2 laser therapy offer rapid onset of effect, fast clearance, and reduction of virus load. However, these procedures are associated with high recurrence rates (RR) of 20%-77% in the short and medium term and do not provide sustained clearance. After laser therapy removal of EGW a RR up to 60% has been reported. Topical sinecatechins 10% is a patient-applied regimen for the treatment of EGW with a low RR (6.5%) at 3 months after completion of the therapy in the pivotal trials conducted so far.